Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-myeloablative Transplant and DLI for CML
NCT00003145Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Aug 1997
- Primary completion
- Mar 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of fludarabine in chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started Aug 1997; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00003145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003145.